Shenzhen Chipscreen Biosciences Balance Sheet Health
Financial Health criteria checks 1/6
Shenzhen Chipscreen Biosciences has a total shareholder equity of CN¥1.6B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 78.4%. Its total assets and total liabilities are CN¥3.3B and CN¥1.7B respectively.
Key information
78.4%
Debt to equity ratio
CN¥1.29b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥481.76m |
| Equity | CN¥1.64b |
| Total liabilities | CN¥1.69b |
| Total assets | CN¥3.34b |
Recent financial health updates
Recent updates
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) 50% Price Boost Is Out Of Tune With Revenues
Oct 08
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Price In Tune With Revenues
Aug 21We Think Shenzhen Chipscreen Biosciences (SHSE:688321) Has A Fair Chunk Of Debt
Jun 04Investors Appear Satisfied With Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Prospects As Shares Rocket 26%
Apr 24Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)
Apr 05Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Shares Climb 30% But Its Business Is Yet to Catch Up
Mar 06Financial Position Analysis
Short Term Liabilities: 688321's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥380.4M).
Long Term Liabilities: 688321's short term assets (CN¥1.1B) do not cover its long term liabilities (CN¥1.3B).
Debt to Equity History and Analysis
Debt Level: 688321's net debt to equity ratio (49.1%) is considered high.
Reducing Debt: 688321's debt to equity ratio has increased from 6.9% to 78.4% over the past 5 years.
Debt Coverage: 688321's debt is not well covered by operating cash flow (2.3%).
Interest Coverage: Insufficient data to determine if 688321's interest payments on its debt are well covered by EBIT.